Primary Mediastinal B-Cell Lymphoma Clinical Trial
Official title:
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
A non-profit study designed with the aim of analysing the phenotype and molecular characteristics (central review) and evaluating prospectively the role of PET-scans in the management of primary mediastinal lymphoma treated with conventional approaches.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT01599559 -
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
|
N/A | |
| Completed |
NCT01953692 -
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
|
Phase 1 | |
| Completed |
NCT00558220 -
R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas
|
Phase 2 | |
| Recruiting |
NCT04735471 -
A Phase 1 Study of ADI-001 in B Cell Malignancies
|
Phase 1 | |
| Completed |
NCT02669017 -
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
|
Phase 1 | |
| Active, not recruiting |
NCT02631044 -
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
|
Phase 1 | |
| Completed |
NCT00924326 -
CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT04911478 -
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
|
||
| Recruiting |
NCT02393157 -
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
|
Phase 2 |